https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
LVEF increased to higher than 50% in 11 patients with HBP (29.73%). The NYHA classification (both p.001), LVEF (both p.001) and LVEDD improved significantly during the follow-up in both groups. NYHA (p=.03, LVEF (p=.013), and LVEDD (p=.003) improved in patients with HBP compared with BVP. HBP was safe and more effective in improving the cardiac function and remodeling in patients with brady-arrhythmias, permanent AF and HFrEF compared with BVP. HBP was safe and more effective in improving the cardiac function and
Like
Comment
Share
